Abstract:Seasonal influenza epidemics occur both in northern and southern hemispheres every year. Despite the differences in influenza virus surface antigens and virulence of seasonal subtypes, manufacturers are well-adapted to respond to this periodical vaccine demand. Due to decades of influenza virus research, the development of new influenza vaccines is relatively straight forward. In similarity with the ongoing coronavirus disease 2019 pandemic, vaccine manufacturing is a major bottleneck for a rapid supply of the billions of doses required worldwide. In particular, egg-based vaccine production would be difficult to schedule and shortages of other egg-based vaccines with high demands also have to be anticipated. Cell culture-based production systems enable the manufacturing of large amounts of vaccines within a short time frame and expand significantly our options to respond to pandemics and emerging viral diseases. In this study, we present an integrated process for the production of inactivated influenza A virus vaccines based on a Madin-Darby Canine Kidney (MDCK) suspension cell line cultivated in a chemically defined medium. Very high titers of 3.6 log(10)(HAU/100 mu l) were achieved using fast-growing MDCK cells at concentrations up to 9.5 x 10(6) cells/ml infected with influenza A/PR/8/34 H1N1 virus in 1 L stirred tank bioreactors. A combination of membrane-based steric-exclusion chromatography followed by pseudo-affinity chromatography with a sulfated cellulose membrane adsorber enabled full recovery for the virus capture step and up to 80% recovery for the virus polishing step. Purified virus particles showed a homogenous size distribution with a mean diameter of 80 nm. Based on a monovalent dose of 15 mu g hemagglutinin (single-radial immunodiffusion assay), the level of total protein and host cell DNA was 58 mu g and 10 ng, respectively. Furthermore, all process steps can be fully scaled up to industrial quantities for commercial manufacturing of either seasonal or pandemic influenza virus vaccines. Fast production of up to 300 vaccine doses per liter within 4-5 days makes this process competitive not only to other cell-based processes but to egg-based processes as well.

Conversion of MDCK Cell Line to Suspension Culture and its Appli cation for Influenza Virus Production

Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines.

Highly Efficient Production of an Influenza H9N2 Vaccine Using MDCK Suspension Cells

Semi-perfusion Cultures of Suspension MDCK Cells Enable High Cell Concentrations and Efficient Influenza A Virus Production.

Reduction in Interferon-Stimulated Genes Contributes to High-Yield Production of Influenza Virus in Suspension MDCK Cells

[Adherent and Single-Cell Suspension Culture of Madin-Darby Canine Kidney Cells in Serum-Free Medium].

A Study on Scale-up Process for Microcarrier Cultue of MDCK Cells Using Low Serum Medium

Development of Scale up for the Production of Influenza Vaccine Based on MDCK Suspension Cells

Rational Design of Medium Supplementation Strategy for Improved Influenza Viruses Production Based on Analyzing Nutritional Requirements of Mdck Cells

Production of influenza H1N1 vaccine from MDCK cells using a novel disposable packed-bed bioreactor

Research on influenza virus cultured in MDCK cells

Production, Passaging Stability, and Histological Analysis of Madin–Darby Canine Kidney Cells Cultured in a Low-Serum Medium

Towards integrated production of an influenza A vaccine candidate with MDCK suspension cells

Optimization of cell culture for H9N2 subtype AIV and establishment of high-yield cell strain

The Screening and Mechanism of Influenza-Virus Sensitive MDCK Cell Lines for Influenza Vaccine Production

Comparison of Influenza Virus Titers Cultured in Vero and MDCK Cells

Establishment and Detection of H1N1 Influenza Virus Adapted Monoclonal MDCK Cell Bank

A Single-Step Method for Harvesting Influenza Viral Particles from MDCK Cell Culture Supernatant with High Yield and Effective Impurity Removal

Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells

Metabolic Reprogramming and Alteration of the Redox State in Hyper-Productive MDCK Cells for Influenza a Virus Production.

Preliminary Optimization of Production Condition of Rabies Virus with MDCKCells Cultured in Serum-free Medium